ResMed | RMD - Net Income


ResMed reported $398.73M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Cochlear AUD 161.5M 69.6M Dec/2025
Cooper Companies USD -77.9M 208.7M Mar/2026
CSL USD 401M 96.5M Dec/2025
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Fisher Paykel Healthcare NZD 255.5M 42.5M Jun/2026
Globus Medical USD 124.3M 16.29M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
Idexx Laboratories USD 338.41M 59.97M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Philips EUR 384M 233M Jun/2026
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 220.3M 27.4M Mar/2026
Teleflex USD -8.15M 706.18M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026